Name: Bringing A Hub-and-Spoke Business Model to Regenerative Medicine by The Bioverge Podcast
Duration: 44 min 31 s
Description: Faizzan Ahmad, Co-Founder and CEO of Cure8bio, sits down with Neil to discuss its growing portfolio of regenerative medicines in development, its hub-and-spoke business model designed to leverage resources and reduce risk, and its push toward curative therapies.

Anthony DePasqua, CEO of EnClear Therapies, sits down with Neil to discuss the company’s technology in development to remove toxic proteins from cerebrospinal spinal fluid to treat patients with ALS and other neurodegenerative conditions.

Removing Toxins from Cerebrospinal Fluid to Treat Neurodegenerative Diseases

Faizzan Ahmad, Co-Founder and CEO of Cure8bio, sits down with Neil to discuss its growing portfolio of regenerative medicines in development, its hub-and-spoke business model designed to leverage resources and reduce risk, and its push toward curative therapies.

Bringing A Hub-and-Spoke Business Model to Regenerative Medicine

Join Neil Littman on The Bioverge Podcast as he explores the intersection of bio x tech and features the entrepreneurs, investors, and industry leaders who are revolutionizing healthcare and bringing science fiction to life.

Bringing A Hub-and-Spoke Business Model to Regenerative Medicine

The Bioverge Podcast

Related tracks